The AMP-Dependent Protein Kinase (AMPK) Activator A-769662 Causes Arterial Relaxation by Reducing Cytosolic Free Calcium Independently of an Increase in AMPK Phosphorylation-Reference-Cited by-同舟云学术

The AMP-Dependent Protein Kinase (AMPK) Activator A-769662 Causes Arterial Relaxation by Reducing Cytosolic Free Calcium Independently of an Increase in AMPK Phosphorylation

Published:2017-10-18 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Huang Yi,Smith Corey A.,Chen Grace,Sharma Bharti,Miner Amy S.,Barbee Robert W.,Ratz Paul H.

Funder

U.S. Department of Defense

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. Effect of simvastatin on vascular smooth muscle responsiveness: involvement of Ca(2+) homeostasis.;Alvarez de Sotomayor;Eur. J. Pharmacol.,2001

2. Lovastatin induces relaxation and inhibits L-type Ca(2+) current in the rat basilar artery.;Bergdahl;Pharmacol. Toxicol.,2003

3. Rho-kinase inhibition attenuates calcium-induced contraction in beta-escin but not Triton X-100 permeabilized rabbit femoral artery.;Clelland;J. Muscle Res. Cell Motil.,2011

4. Distinct effects of contraction agonists on the phosphorylation state of cofilin in pulmonary artery smooth muscle.;Dai;Adv. Pharmacol. Sci.,2008

5. AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signaling and inhibits NO-induced relaxation.;Davis;Eur. J. Pharmacol.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing Metformin for Vascular Disease;Current Medicinal Chemistry;2023-10

2. Contribution of calcium dysregulation to impaired coronary artery contraction in Zucker diabetic fatty rats;Clinical and Experimental Pharmacology and Physiology;2022-11-30

3. Effect of mitochondrial complex III inhibitors on the regulation of vascular tone in porcine coronary artery;European Journal of Pharmacology;2021-04

4. Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function;Frontiers in Pharmacology;2020-05-08

5. Vascular adenosine monophosphate‐activated protein kinase: Enhancer, brake or both?;Basic & Clinical Pharmacology & Toxicology;2019-11-24